Original investigation
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era

https://doi.org/10.1016/0272-6386(95)90649-5Get rights and content

Abstract

The purpose of this study was to evaluate the sensitivity and specificity of laboratory methods in the diagnosis of posterythropoietin-era, iron-deficient, chronic renal failure patients. The patient population comprised 25 anemic (hemoglobin <11 g/dL) patients with creatinine greater than 3 mg/dL; 20 were dialysis patients, two were transplant patients, and three patients had renal failure from other causes. Criteria for study inclusion were as follows: bone marrow iron was the reference standard and was graded 0 to +4, ranging from absent to diffuse homogeneous iron staining; serum ferritin concentration and serum transferrin saturation were tested in terms of sensitivity and specificity. The reference standard indicated that iron deficiency existed in 40% of patients. Neither serum ferritin nor transferrin saturation were completely adequate diagnostic tools. Serum ferritin levels less than 200 ng/dL were 100% specific for the diagnosis but only 41% sensitive. Transferrin saturation of less than 20% was 88% sensitive, but only 63% specific. By excluding patients with hypoproteinemia (transferrin values of <150 mg/dL), the sensitivity of the test increased to 100% and the specificity to 80%. We conclude that transferrin saturation is an adequate screening tool in anemic chronic renal failure patients, provided that hypoproteinemia is not present. By determining both the serum ferritin concentration and the transferrin saturation, a high sensitivity and specificity can be achieved, even in patients with hypoproteinemia. Furthermore, we believe that on this basis, iron therapy in patients with renal insufficiency can be improved.

References (34)

  • Y Ohe et al.

    Part 1: Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method—The clinical significance. Part 2: Relation to serum iron, iron binding capacity, and ferritin in renal failure and hematological disorders

    Rinsho Byori

    (1993)
  • ME Rosenberg

    Role of transferrin measurement in monitoring iron status during recombinant human erythropoietin therapy

    Dial Transplant

    (1992)
  • S Garrett et al.

    Zinc protoporphyrin and iron deficient erythropoiesis

    Acta Haematol

    (1994)
  • T Hotta et al.

    Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure

    Int J Hematol

    (1991)
  • TB Drueke

    Resistance to recombinant human erythropoietin in hemodialysis patients

    Am J Nephrol

    (1990)
  • DB Van Wyck

    Iron management during recombinant human erythropoietin therapy

    Am J Kidney Dis

    (1989)
  • BL Warschaw et al.

    Decreased serum transferrin concentration in children with the nephrotic syndrome

    Clin Immunol Immunopathol

    (1984)
  • Cited by (0)

    View full text